Dr. Nina Wagner-Johnston is Professor of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include non-Hodgkin lymphoma, Hodgkin lymphoma, and HIV-related lymphomas. Dr. Wagner-Johnston serves as the Director for the Lymphoma Drug Development Program at the Johns Hopkins University. Dr. Wagner-Johnston received her baccalaureate degree in nursing from Georgetown University in Washington, DC. She earned her MD and completed her residency training at the University of Chicago, Chicago Illinois. She performed a fellowship in Medical Oncology at Johns Hopkins University, Baltimore, Maryland. Dr. Wagner-Johnston joined the Johns Hopkins faculty in 2015. Prior to joining Johns Hopkins, Dr. Wagner-Johnston was an Assistant Professor at Washington University, St. Louis, Missouri. Her research interests include clinical trial and biomarker development for patients with lymphoma. She is additionally involved in palliative/supportive care research and has a particular interest in chemotherapy-induced peripheral neuropathy. Dr. Wagner-Johnston serves as a member on the NCCN Cancer Related Fatigue Guidelines Panel and the ASCO Neuropathy Guidelines Panel. She has served as a journal reviewer for Annals of Oncology, Leukemia and Lymphoma, Blood, and the Journal of Nuclear Medicine. She is a previous recipient of a Young Investigator Award at the Supportive Oncology Conference as well as a Mentoring Program Award through the American Academy of Hospice and Palliative Medicine. She has served on the National Cancer Institute (NCI) Lymphoma Steering Committee Clinical Trials Design Committee and the NCI Symptom Management and Health Related Quality of Life Steering Committee. She is a member of the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the AIDS Malignancies Consortium (AMC), and the Eastern Cancer Oncology Group (ECOG) Lymphoma Committee. Dr. Wagner is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. Her top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Yarmus is a Professor of Medicine and Oncology and the director of Interventional Pulmonology at the Johns Hopkins University School of Medicine as well as the Vice Chair of Medicine for Strategy and Finance. He is an expert in the minimally invasive diagnosis and treatment of lung cancer and he leads the Interventional Pulmonary research program at Johns Hopkins with research investigating innovative minimally invasive device development and early-stage bronchoscopic treatments. He also has extensive experience in the minimally invasive management of malignant airway obstruction, complex airway management, pleural diseases and symptom relief with minimally invasive procedures such as indwelling pleural catheters and pleurodesis. Dr. Yarmus is a member of the Fleischner Society and a fellow of the American College of Chest Physicians and the American Thoracic Society. Dr. Yarmus is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Pleural Effusion, Lung Nodules, Lymphofollicular Hyperplasia, Endoscopy, and Advanced Bronchoscopy.

Dr. Lee is a specialist in Interventional Pulmonary and serves as the Wang Interventional Pulmonary Fellowship Director. His areas of clinical expertise include interventional pulmonology, pleural disease, minimal invasive diagnostics and lung cancer at Johns Hopkins. He also has extensive experience in the minimally invasive management of malignant airway obstruction, complex airway management and difficulty airways. In addition, he specializes in the diagnosis and management of pleural diseases and symptom relief with minimally invasive procedures. He is a fellow of the American College of Chest Physicians and the Johns Hopkins Master of Education for Health Professionals. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Pleural Effusion, Lung Nodules, Lymphofollicular Hyperplasia, Endoscopy, and Advanced Bronchoscopy.

Brian Monroe is a Radiologist in Windsor Mill, Maryland. Dr. Monroe is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Lymphofollicular Hyperplasia, Thyroid Nodule, Lung Cancer, Bone Marrow Aspiration, and Gastrostomy.

Charles Yim is a Radiologist in Windsor Mill, Maryland. Dr. Yim is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Ascites, Lymphofollicular Hyperplasia, Pleurisy, Bone Marrow Aspiration, and Gastrostomy.

Gerald Hayward is a General Surgeon in Catonsville, Maryland. Dr. Hayward is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Hernia, Cholecystitis, Hemangiopericytoma, Hernia Surgery, and Small Bowel Resection.

Cristina Campassi is a Radiologist in Windsor Mill, Maryland. Dr. Campassi has been practicing medicine for over 37 years and is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. Her top areas of expertise are Breast Lump, Galactocoele, Giant Mammary Hamartoma, and Fibroadenoma.

Gavin Henry is a General Surgeon and a Thoracic Surgeon in Baltimore, Maryland. Dr. Henry is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, ALK-Positive Non-Small Cell Lung Cancer, Thymectomy, and Advanced Bronchoscopy.

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as an Advanced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Pancreaticoduodenectomy.

Jeffrey Thiboutot is a primary care provider, practicing in Pulmonary Medicine in Baltimore, Maryland. Dr. Thiboutot is rated as an Advanced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Lung Nodules, Pleurisy, Lymphofollicular Hyperplasia, Lung Cancer, and Endoscopy.

Christine Argento is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Argento is rated as an Advanced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. Her top areas of expertise are Pleural Effusion, Lymphofollicular Hyperplasia, Lung Nodules, Endoscopy, and Gastrostomy.

Dr. Mullen attended the University of Virginia, graduating in 1987 with a BA in Chemistry and Spanish. She then attended medical school at Columbia University College of Physicians and Surgeons, graduating in 1991. After an internship in Internal Medicine at the Hospital of the University of Pennsylvania, she returned to Columbia Presbyterian Medical Center (now New York Presbyterian Hospital) for her residency in Diagnostic Radiology. She served at Co-Chief Resident from 1995 to 1996. Dr. Mullen completed her fellowship in Cross-Sectional Imaging (Ultrasound, CT and MRI) at Johns Hopkins Hospital in 1997. Dr. Mullen worked in private practice for 5 years, gaining experience in general radiology, and developing interest and expertise in breast imaging, women's imaging, and body imaging. She joined Johns Hopkins Radiology in 2002, and has been based at Johns Hopkins Imaging at Green Spring. Dr. Mullen has expertise in screening and diagnostic mammography, breast ultrasound, breast MRI, and breast interventional procedures, as well as general ultrasound and bone densitometry. Dr. Mullen is interested in clinical breast imaging and resident and fellow education. She has been the Breast Imaging Fellowship Director since 2013. Dr. Mullen is rated as an Advanced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. Her top areas of expertise are Fibrocystic Breast Disease, Lymphofollicular Hyperplasia, Osteopenia, and Melorheostosis with Osteopoikilosis.

Danilo Espinola is a Radiologist in Windsor Mill, Maryland. Dr. Espinola is rated as an Advanced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Lung Nodules, Melorheostosis, Melorheostosis with Osteopoikilosis, and Osteopenia.

Zuzana Chamrova is a Radiologist in Windsor Mill, Maryland. Dr. Chamrova is rated as an Advanced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. Her top areas of expertise are Ascites, Endometrial Cancer, Pleurisy, Bone Marrow Aspiration, and Vertebroplasty.

Joseph Bennett is a General Surgeon and a Surgical Oncologist in Randallstown, Maryland. Dr. Bennett is rated as an Advanced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Pancreatic Adenoma, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Bennett is currently accepting new patients.

Winko Zan is a primary care provider, practicing in Family Medicine in Catonsville, Maryland. Dr. Zan is rated as an Advanced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Bronchitis, Flu, COVID-19, and Multisystem Inflammatory Syndrome in Children (MIS-C).

Van Holden is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Holden is rated as an Advanced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, Endoscopy, and Gastrostomy.

Ashutosh Sachdeva is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Sachdeva is rated as an Advanced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Small Cell Lung Cancer (SCLC), Pleural Effusion, ALK-Positive Non-Small Cell Lung Cancer, Endoscopy, and Advanced Bronchoscopy.

Nima Tishbi is a Radiologist in Baltimore, Maryland. Dr. Tishbi is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Pleurisy, Pleural Effusion, Lung Nodules, and Idiopathic Dilatation of the Pulmonary Artery.

Saiyad Sarkar is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Sarkar is rated as an Advanced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Lung Cancer, Lung Nodules, Pleural Effusion, Advanced Bronchoscopy, and Endoscopy.